SAMHD1 and non-small cell lung carcinoma: Similar results were obtained with OS since therapy initiation was evaluated; a shorter OS was observed in SAMHD1 positive patients than in SAMHD1 negative patients, only for ovarian and NSCLC tumors (log rank function, p = 0.060 and p = 0.014, respectively).